1Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation[J]. Throb Haemost,2001,86 : 1327-1330.
2Chu AJ, Wang GZ, Walton MA,et al. Involvement of MAPK Activation in Bacterial Endotoxin-inducible tissue Factor Upregulation in Human Monocytic THP-1 cells[J].J Surg Res,2001,101 ( 1 ) ;85-90.
3Oelschlager C, Romisch J, Staubitz A, et al. Antithrombin Ⅲ inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells[J]. Blood, 2002, 99( 11 ) :4015-4020.
4Esmon CT. Inflammation and thrombosis[J]. J Thromb Haemost,2003, 1:1343-1348.
5Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation[ J ]. Semin Thromb Hemost, .2001,27(6) :605-617.
6Gando S, Nanzaki S, Sasaki S, et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock[J]. Crit Care Med, 2000,26:2005-2009.
8Huntington JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis[J]. J Thromb Haernost 2003,1 : 1535-1549.
9de Jonge E, van der Poll T, Kesecloglu J, et al. Anticoagulation factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience [ J ]. Semin Thromb Hemost,2001,27:667:674.
10Minnema MC, Chang AC, Jansen PM, et al. Recombinant human antithrombin Ⅲ improves survival and attenuates inflammatory responses in baboons lethally chanllenged with Escherichia coli[ J ].Blood, 2000,95(4) :1117-1123.
